https://stanfordhealthcare.org/publications/835/835979.html
835979 | Stanford Health Care
SUNFISH Part 2: 24-month Efficacy and Safety of Risdiplam in Patients with Type 2 or Non-ambulant Type 3 Spinal Muscular Atrophy (SMA)
stanfordhealthcare
https://danbooru.donmai.us/users/835979
@user 835979 | Danbooru
userdanbooru